ORCL
49
3
UPS
51
6
MTB
38
4
EXR
42
5
CCI
30
2
UNP
38
5
CHD
34
7
NEM
30
2
PWR
63
3
PM
49
8
KR
50
5
NOV
45
2
GE
60
5
ADP
57
2
FMC
23
7
SWK
53
4
CCL
68
6
NRG
32
5
ETN
64
4
VIX
41
-11
ORCL
49
3
UPS
51
6
MTB
38
4
EXR
42
5
CCI
30
2
UNP
38
5
CHD
34
7
NEM
30
2
PWR
63
3
PM
49
8
KR
50
5
NOV
45
2
GE
60
5
ADP
57
2
FMC
23
7
SWK
53
4
CCL
68
6
NRG
32
5
ETN
64
4
VIX
41
-11
Financhill
Back

Candel Therapeutics Quote, Financials, Valuation and Earnings

These 7 Stocks Will Be Magnificent in 2025

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Buy
59

CADL
Candel Therapeutics

Last Price:
$8.74
Seasonality Move:
-11.47%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Candel Therapeutics Price Quote

$8.74
-0.01 (-12.25%)
(Updated: December 21, 2024 at 5:18 AM ET)

Candel Therapeutics Key Stats

Buy
59
Candel Therapeutics (CADL) is a Buy
Day range:
$8.25 - $10.00
52-week range:
$1.08 - $14.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2,118.19
P/B ratio:
25.38%
Volume:
4.8M
Avg. volume:
6.6M
1-year change:
681.25%
Market cap:
$284.2M
Revenue:
$0
EPS:
$-1.73

How Much Does Candel Therapeutics Make?

Data Unavailable

Is Candel Therapeutics Growing As A Company?

Data Unavailable

Candel Therapeutics Stock Price Performance

What Is Candel Therapeutics 52-Week High & Low?

Candel Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Candel Therapeutics?

Data Unavailable

Is Candel Therapeutics Cash Flow Positive?

Data Unavailable

Candel Therapeutics Return On Invested Capital

Data Unavailable

Candel Therapeutics Earnings Date & Stock Price

Candel Therapeutics Competitors

  • Who Are Candel Therapeutics's Competitors?
    Below is a list of companies who compete with Candel Therapeutics or are related in some way:
    • AnaptysBio Inc (ANAB)
    • Bristol-Myers Squibb Co (BMY)
    • Inovio Pharmaceuticals Inc (INO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Pfizer Inc (PFE)

Candel Therapeutics Dividend Yield

Data Unavailable

Candel Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 19.00
Upside from Last Price: 117.14%

Major Shareholders

Data Unavailable